IBDEI0IQ ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8427,2)
 ;;=^5019595
 ;;^UTILITY(U,$J,358.3,8428,0)
 ;;=R80.8^^39^398^97
 ;;^UTILITY(U,$J,358.3,8428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8428,1,3,0)
 ;;=3^Proteinuria,Other
 ;;^UTILITY(U,$J,358.3,8428,1,4,0)
 ;;=4^R80.8
 ;;^UTILITY(U,$J,358.3,8428,2)
 ;;=^5019598
 ;;^UTILITY(U,$J,358.3,8429,0)
 ;;=R80.3^^39^398^93
 ;;^UTILITY(U,$J,358.3,8429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8429,1,3,0)
 ;;=3^Proteinuria Bence Jones
 ;;^UTILITY(U,$J,358.3,8429,1,4,0)
 ;;=4^R80.3
 ;;^UTILITY(U,$J,358.3,8429,2)
 ;;=^13272
 ;;^UTILITY(U,$J,358.3,8430,0)
 ;;=R80.9^^39^398^98
 ;;^UTILITY(U,$J,358.3,8430,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8430,1,3,0)
 ;;=3^Proteinuria,Unspec
 ;;^UTILITY(U,$J,358.3,8430,1,4,0)
 ;;=4^R80.9
 ;;^UTILITY(U,$J,358.3,8430,2)
 ;;=^5019599
 ;;^UTILITY(U,$J,358.3,8431,0)
 ;;=Z87.442^^39^398^86
 ;;^UTILITY(U,$J,358.3,8431,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8431,1,3,0)
 ;;=3^Personal Hx of Urinary Calculi
 ;;^UTILITY(U,$J,358.3,8431,1,4,0)
 ;;=4^Z87.442
 ;;^UTILITY(U,$J,358.3,8431,2)
 ;;=^5063497
 ;;^UTILITY(U,$J,358.3,8432,0)
 ;;=N18.1^^39^398^15
 ;;^UTILITY(U,$J,358.3,8432,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8432,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 1
 ;;^UTILITY(U,$J,358.3,8432,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,8432,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,8433,0)
 ;;=N18.2^^39^398^16
 ;;^UTILITY(U,$J,358.3,8433,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8433,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 2
 ;;^UTILITY(U,$J,358.3,8433,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,8433,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,8434,0)
 ;;=N18.4^^39^398^20
 ;;^UTILITY(U,$J,358.3,8434,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8434,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 4
 ;;^UTILITY(U,$J,358.3,8434,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,8434,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,8435,0)
 ;;=N18.5^^39^398^21
 ;;^UTILITY(U,$J,358.3,8435,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8435,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 5
 ;;^UTILITY(U,$J,358.3,8435,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,8435,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,8436,0)
 ;;=Q61.3^^39^398^89
 ;;^UTILITY(U,$J,358.3,8436,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8436,1,3,0)
 ;;=3^Polycystic Kidney,Unspec
 ;;^UTILITY(U,$J,358.3,8436,1,4,0)
 ;;=4^Q61.3
 ;;^UTILITY(U,$J,358.3,8436,2)
 ;;=^5018797
 ;;^UTILITY(U,$J,358.3,8437,0)
 ;;=N20.1^^39^398^11
 ;;^UTILITY(U,$J,358.3,8437,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8437,1,3,0)
 ;;=3^Calculus Ureter
 ;;^UTILITY(U,$J,358.3,8437,1,4,0)
 ;;=4^N20.1
 ;;^UTILITY(U,$J,358.3,8437,2)
 ;;=^5015608
 ;;^UTILITY(U,$J,358.3,8438,0)
 ;;=N18.9^^39^398^22
 ;;^UTILITY(U,$J,358.3,8438,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8438,1,3,0)
 ;;=3^Chronic Kidney Failure,Unspec
 ;;^UTILITY(U,$J,358.3,8438,1,4,0)
 ;;=4^N18.9
 ;;^UTILITY(U,$J,358.3,8438,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,8439,0)
 ;;=N18.6^^39^398^32
 ;;^UTILITY(U,$J,358.3,8439,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8439,1,3,0)
 ;;=3^End Stage Renal Disease (ESRD)
 ;;^UTILITY(U,$J,358.3,8439,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,8439,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,8440,0)
 ;;=N52.9^^39^398^49
 ;;^UTILITY(U,$J,358.3,8440,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8440,1,3,0)
 ;;=3^Erectile Dysfunction,Unspec
 ;;^UTILITY(U,$J,358.3,8440,1,4,0)
 ;;=4^N52.9
